Celsius (NASDAQ:CELH) Rating Lowered to Sell at Wall Street Zen

Celsius (NASDAQ:CELH - Get Free Report) was downgraded by Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Saturday.

A number of other brokerages have also recently issued reports on CELH. Piper Sandler increased their price objective on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a report on Wednesday, June 4th. Truist Financial lifted their price target on Celsius from $45.00 to $50.00 and gave the stock a "buy" rating in a research note on Friday, June 6th. Roth Capital restated a "buy" rating and set a $52.00 target price (up from $46.00) on shares of Celsius in a report on Thursday, June 26th. JPMorgan Chase & Co. boosted their price target on shares of Celsius from $39.00 to $44.00 and gave the company an "overweight" rating in a research report on Friday, May 2nd. Finally, LADENBURG THALM/SH SH reduced their target price on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $45.18.

Celsius Trading Up 0.1%

Shares of CELH opened at $46.43 on Friday. Celsius has a 12 month low of $21.10 and a 12 month high of $60.70. The company has a market capitalization of $11.97 billion, a price-to-earnings ratio of 145.08, a PEG ratio of 1.66 and a beta of 1.45. The stock has a 50 day moving average of $39.71 and a 200 day moving average of $32.79.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). The company had revenue of $329.28 million during the quarter, compared to the consensus estimate of $349.09 million. Celsius had a return on equity of 42.12% and a net margin of 8.40%. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period last year, the firm posted $0.27 EPS. As a group, equities research analysts predict that Celsius will post 0.89 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO John Fieldly sold 130,803 shares of the company's stock in a transaction on Tuesday, June 24th. The stock was sold at an average price of $45.00, for a total transaction of $5,886,135.00. Following the completion of the sale, the chief executive officer owned 1,038,577 shares in the company, valued at approximately $46,735,965. This represents a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder William H. Milmoe sold 300,000 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total transaction of $14,181,000.00. Following the completion of the transaction, the insider owned 18,017,770 shares in the company, valued at $851,699,987.90. This trade represents a 1.64% decrease in their position. The disclosure for this sale can be found here. Insiders sold 562,974 shares of company stock valued at $25,758,418 over the last quarter. Company insiders own 2.55% of the company's stock.

Hedge Funds Weigh In On Celsius

Several institutional investors and hedge funds have recently bought and sold shares of CELH. Alliancebernstein L.P. raised its stake in Celsius by 26.3% during the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock valued at $642,769,000 after purchasing an additional 3,753,055 shares during the period. Champlain Investment Partners LLC bought a new position in shares of Celsius during the 4th quarter worth $85,068,000. Contrarius Group Holdings Ltd bought a new position in Celsius during the 4th quarter worth about $75,535,000. Norges Bank purchased a new position in Celsius during the fourth quarter valued at approximately $72,579,000. Finally, Alyeska Investment Group L.P. lifted its holdings in Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock worth $181,164,000 after buying an additional 2,591,345 shares during the period. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.